Health Canada introduces a reliance framework to accelerate access to treatments, beginning with pediatric and veterinary drugs.
Pharma
The Federal Trade Commission says the settlement will increase transparency and competition across the entire drug supply chain.
The FDA’s rule would simplify registration for DMEs and heighten visibility for foreign drug supply sources.
As Anthropic pushes deeper into life sciences, the FDA is sharpening rules around AI‑enabled research and the use of computational predictions in regulated development pipelines.
Regulatory experts say the pattern signals that heightened scrutiny of drug advertising under the Trump administration is likely to continue.
The Trump administration says it will examine whether Germany’s reimbursement practices constitute “persistent underpayment” for new drugs or “burden or restrict US commerce.”
America’s early-stage clinical trials have increasingly moved overseas, raising concerns about the nation’s long-term competitiveness in biomedical innovation.
The update aims to clarify how manufacturers should approach similarity assessments, indication extrapolation, and post-market safety monitoring.